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1 
SUMMARY 
146 cases of schizophrenia, fulfilling Research Diagnostic Criteria and a regular followup of 6 monthi or 
more, were studied concerning depressive mood disorders at the onset of illness and over a period of time following 
neuroleptic treatment. There was no significant difference in the total number of cases depressed at the onset oT 
illness (49) and at final follow up (56). Following 8 weeks of neuroleptic treatment, depressive symptoms disap-
peared in 47 per cent of the depressed schizophrenics and these cases did not evince depression subsequently. Ho-
wever, 53 per cent ot schizophrenics manifesting depression at final followup had no depressive symptoms at the 
onset ot illness and in these cases depression occurred following neuroleptic treatment. It is contended that depres-
sion may be intrinsic of schizophrenia and neuroleptics may Have a role in the causation of depressive disorders 
in schizophrenia. 
The occurrence of depressive symp-
toms in the course of schizophrenia was re-
cognized by Bleuler (1911) and Kraepelin 
(1919). Mayor-Gross (1920) found that 
some patients emerged from psychosis into 
a state of despair, which he regarded as a 
mode of reacting to a psychotic experience. 
Depressive mood disorders associated 
with schizophrenia have received consi-
derable attention in the recent years; ho-
wever, the etiology of such depressive 
states has remained a persistent enigma. 
Depressive symptoms have been encoun-
tered in schizophrenia at the very onset of 
psychotic symptoms (Planansky and Johns-
ton 1978) and during acute exacerbations 
of psychotic symptoms (Knights and 
Hirsch 1981). Depressive disorders have 
been reported in the course of chronic schi-
zophrenia (Roy et al 1983). A serious de-
pression in the aftermath of a schizophrenic 
episode has been described by several au-
thors (Steinberg et al 1967, Bowers and As-
trachan 1967, Roth 1970, Stern et al 1972, 
McGlashan and Carpenter 1976a, 1976b, 
Mackinnon 1977, Das and Kapur 1980 & 
Mandel et al 1982). 
Depressive syndrome that follows the 
resolution of flagrant psychotic symptoms 
in schizophrenia has often been described 
as postpsychotic depression (McGlashan 
and Carpenter 1976a), characterized symp-
tomatically by sadness, suicidal ideas, mas-
sive inertia, neurasthenic complaints, fee-
lings of emptiness or absence of feelings, 
striking passivity and impairment of inter-
personal relations. 
Postpsychotic depression has been re-
garded as a serious clinical entity requiring 
the institution of appropriate psychological 
or somatic treatments. Another related de-
cision concerning management regards 
that the extent to which a patient with 
postpsychotic depression should be urged 
to resume premorbid functioning. Vigor-
ous efforts at rehabilitation during this time 
may constitute a negative force (Miller and 
Sonnenberg 1973) and as the anergia is 
transient (may last from weeks to more 
than a year), patient should be urged to as-
sume only those responsibilities that he can 
shoulder with comfort (Detrc and Jarecki 
1971). 
The incidence of suicide is high in schi-
zophrenia (Warnes 1968, Planansky and 
Johnston 1971) and it is estimated that 
about 10 per cent of all schizophrenics kill 
themselves (Miles 1977). An impending de-
pressive state may still further increase the 
risk of suicide in schizophrenics recovering 
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Irom psychotic symptoms, as they must 
contend with unalterable reality ot their ill-
ness, their problems and their uncertain fu-
ture (McCilashan and (Carpenter 1976a). A 
substantial percentage ot chronic schizoph-
renics also attempt suicide at sometime in 
their illness and the suicide risk is greatcr'in 
those who develop a major depressive epi-
sode (Roy et al 1984). 
Despite the importance of recognition 
of depressive states in schizophrenia, there 
has been a curious dearth of data in the In-
dian set up. In this study an attempt has 
been made to study the frequency and na-
ture of depressive disorders in schizophre-
nia. 
Material and Methods 
All the adult new cases seen at the psy-
chiatric out-patient department of Kas-
turba Medical College Hospital, Manipal, 
Karnataka from January 1978 to December 
1979 constituted the material. ICD-9 
(WHO 1978) criteria were used for diag-
nosis of schizophrenia. 2,179 adult new 
cases (15 years and above) were seen during 
this period and 529 cases (24%) constituted 
schizophrenia, as per ICD-9 criteria. The 
following were excluded from the study: 
1. Patients with major physical illness. 
2. Evidence of organicity, even if organ-
ic disorder could not be identified. 
3. Evidence of alcohol or drug abuse or 
their withdrawal. 
4. Latent schizophrenia. 
5. Schizo-affective schizophrenia (schi-
zophrenia with pronounced affective 
symptoms, depressive or manic). 
6. Doubtful diagnoses of schizophrenia. 
7. Schizophrenia-like psychoses, with 
antecedent stressful life events. 
All the cases received conventional neu-
roleptic treatment and antiparkinsonian 
medication (hen/hexol) was routinely gi-
ven concomitantly (electroconvulsive the-
rapy was used in some cases of catatonic 
schizophrenia and in a tew cases ot other 
types ot schizophrenia w-ith little response 
to drugs, at the discretion ot treating con-
sultant). Cases with diagnostic or manage-
ment problems received in-patient observa-
tion and treatment, ranging from 3 to 6 
weeks. 
The cases were followed up fortnightly 
in the first month and monthly or bimonth-
ly afterwards, depending on the severity. A 
register of these cases and their follow up 
was maintained and it any case had not 
turned up tor follow up as advised, a letter 
was despatched requesting tor a tollowup. 
The tollowup period ranged from a mini-
mum of 6 months to a maximum of 48 
months from first visit. 
The patients who were considered defi-
nite cases ot schizophrenia were studied 
concerning symptomatology at first visit, 
and at each followup. At the first visit, 
symptoms noted at a thorough clinical 
mental status examination and/or during 
preceding one week were coded in the case 
record, that had a structured list of 93 
symptoms, covering 15 major aspects of 
psychiatric phenomenology: general ap-
pearance, behaviour, psychomotor activity, 
speech, affect, thought disorder, delusions, 
hallucinations, catatonic features, neurotic-
symptoms, sexual disturbances, memory', 
orientation, appetite and sleep. At each fol-
lowup, symptoms noted at a detailed men-
tal status examination were recorded in the 
case-sheets. The cases, even the ones with 
indubitable diagnosis ot schizophrenia, that 
had not a minimum regular followup of 6 
months were excluded from the study, as 
this much duration was thought necessary 
for a clear-cut picture to emerge, and to stu-
dy the phenomenology over a course ot 
time. S. S. RAJU  in 
As the criteria for the diagnosis of schi-
zophrenia in ICD-9 were not very specific, 
Research Diagnostic Criteria (Spitzer et al 
1978) were applied retrospectively to these 
cases, at the time of final assessment done in 
December 1981. The cases that satisfied 
die RDC criteria for definite schizophrenia 
and a minimum regular followup of 6 
months or more were only considered for 
final analysis. Schizophrenics were not ca-
tegorized into RDC sub-types for this stu-
dy. The depressive symptoms recorded in 
the files were scrutinised and analysed as 
per the RDC criteria for different types of 
depressive syndromes. 
Results 
Out of 529 cases of schizophrenia 146 
cases satisfied the criteria laid down in this 
study. 
At first presentation, out of 146 schi-
zophrenics, 49 cases (34%) showed notice-
able depressive symptoms, which as de-
fined in this study were :One or more dis-
tinct periods with dysphoric mood (de-
pressed, sad, hopeless) or pervasive loss of 
interest or pleasure that lasted at least one 
week from the onset of a noticeable change 
in the patient's usual condition, associated 
with at least 2 of the following symptoms-
poor appetite ; sleep difficulty; loss of inte-
rest or pleasure in usual activities, including 
social contact or sex; feelings of self-re-
proach or excessive or inappropriate guilt; 
slowed thinking or indecisiveness; recur-
rent thoughts of death or suicide or any sui-
cidal behaviour. These symptoms repre-
sented A and only 2 symptoms of B of RDC 
criteria for a definite diagnosis of schizoaf-
fective disorder, depressed type and these 
were not sufficient for a schizo-affective 
diagnosis. Schizophrenics showing mo-
mentary shifts from one dysphoric mood to 
another dysphoric mood, e.g. anxiety to de-
pression to anger, or those manifesting 
fleeting depressive symptomatology (that 
were insufficient to meet the specified cri-
teria) were disregarded. 
After 8 weeks of neuroleptic treatment 
(no antidepressants were given), it was 
found that, out of 49 cases of schizophrenia 
who had manifested depressive symptoma-
tology at first visit, in 23 cases (47%) depres-
sive symptoms had abated and they did not 
manifest depression subsequently; still, in 
26 cases depressive symptoms persisted and 
these formed part of the cases who evinced 
depression at final assessment. 
Followup: Out of 146 cases of schizophre-
nia, 15 cases could be followed up for 6 
months only and these warranted descrip-
tion separately from the remaining 131 
cases who were followed for more than 6 
months. • 
Out of 15 cases of schizophrenia who 
could be followed for 6 months only, de-
pressive symptoms were persisting in 2 
cases at the end oi 8 weeks of neuroleptic 
treatment and subsequently these 2 cases 
(13%) progressed to develop major depres-
sive disorder superimposed on residual 
schizophrenia; and the other 13 cases (87%) 
showed no evidence of depression. 
In 131 cases, where followup exceeded 
6 months, the last visit the patients had 
made prior to the end of December 1981 
was taken as the final followup visit. Ho-
wever, the duration of followup, from first 
visit to 'final' visit, was not uniform in all 
the cases:24 cases had 7-12 months follo-
wup; 25 cases-13-18 months; 32 cases -
19-24 months; 19 cases-25-30 months; 12 
cases-31-36 months; 9 cases-37-42 
months; 10 cases-43-48 months. 
The entire followup period, commenc-
ing with the first followup visit after 8 
weeks of neuroleptic therapy and extend-
ing upto the final followup visit was 
screened for depressive symptomatology. 
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present at first visit, were persisting in 24 
cases after 8 weeks of neuroleptic treat-
ment. Depressive symptoms emerged for 
the first time in 7 cases between 2 and 6 
months of followup; in 12 cases, between 7 
and 12 months; 4 cases, between'13 and 18 
months; 3 cases, between 19 and 24 
months; 2 cases, between 3land 36 
months; 2 cases between 37 and 42 
months. 
Thus out of 131 cases of schizophrenia, 
in the follow up period, 77 cases (59%) did 
not manifest 'noticeable' depressive 
symptoms and 54 cases (41%) manifested 
varying degrees of depression, the na-
ture of which was assessed as per the RDC 
criteria for different types of depressive 
syndromes. 
14 cases of schizophrenia (10%), in 
whom prominent psychotic symptoms had 
abated, yet residual symptoms like emoti-
onal blunting, extreme social withdrawal, 
eccentric behaviour or mild formal thought 
disorder persisted, developed pronounced 
depressive symptoms, that persisted for 
more than 2 weeks without any activation 
of psychotic schizophrenic features. The 
depressive symptoms were sufficiently se-
vere to qualify for the full depressive synd-
rome (A & B of major depressive disorder 
in RDC). These cases were labelled as "de-
pressive syndrome superimposed on resi-
dual schizophrenia (secondary depres-
sion)", as per RDC criteria. 
33 cases (25%) in whom residual schi-
zophrenic symptoms had persisted, re-
vealed 'noticeable' depressive symptoms 
which were not sufficiently severe to quali-
fy for major depressive disorder. However, 
the depressive symptoms noted in these 
cases were sufficient to meet the criteria A, 
B & C (but not D, E & F) of minor depres-
sive disorder in RDC. 
4 cases (3%) developed schizo-affectivc 
disorder - depressed type i.e. symptoms of 
major depressive disorder overlapped tem-
porally with active period of schizophrenic 
symptoms (delusions, hallucinations, for-
mal thought disorder or grossly disorga-
nised behaviour). 
3 cases (2%) in whom schizophrenic 
symptoms had fully remitted, developed a 
depressive syndrome that met the criteria 
(A, B, C, D, E & F) of definite major depres-
sive disorder in RDC. These were given the 
RDC label of "secondary major depressive 
disorder". 
Discussion 
Schizophrenic pjtients, in the present 
study, manifested depressive symptomato-
logy at first presentation and over a course 
of time following treatment. 
At first presentation, depressive symp-
toms were evident in 34 per cent of the un-
treated schizophrenics in this study. A large 
number of reports are now available con-
cerning the Irequency of depressive symp-
toms in Schizophrenia and some of the rec-
ent studies reported higher prevalence of 
depression in acutely admitted schizophre-
nia, nearly 50 per cent of cases or more 
(Knights and Hirsch 1981, Johnson 1981). 
The estimate of the frequency of depres-
sion in the present study can be regarded as 
conservative, as schizophrenics manifesting 
depressive symptoms insufficient to meet 
the specified criteria were disregarded. De-
pression may be a ubiquitous conconutant 
of schizophrenia, that gets overlooked cli-
nically because of other more florid psy-
chotic symptoms and when the psychosis 
remits depression becomes evident 
(McGlashan and Carpenter 1976, Moller 
and Zcrssen 1982). From the present study, 
it appears that depressive symptoms may be 
integral of schizophrenia as these symp-
toms have occurred at the very onset of 
schizophrenia. However, depressive symp-
toms, in the present study, have not been 
found to be invariably associated with the onset of schizophrenia. 
It is notable that in 47 percent of schi-
zophrenics with 'noticeable' depressive 
symptoms, the depressive symptoms had 
abated following 8 weeks of neuroleptic 
therapy- It has been pointed out that some 
neuroleptics have antidepressant properties 
(Robertson and Trimple 1983, Becker 
j983). However, it is also quite possible 
that antipsychotic drugs, at least some of 
the commonly used ones, have, in fact, no 
distinct antidepressant properties and that 
depression integral of schizophrenia disap-
pears in some cases following neuroleptic-
mduced improvement in schizophrenia. 
In this study, out of 15 cases of schi-
zophrenia who could be followed for 6 
months only, only 2 cases developed major 
depressive disorder superimposed on resi-
dual schizophrenia and both these cases 
had 'noticeable' depressive symptoms at the 
onset, whereas at followup the depression 
was more pronounced and conspicuous. 
In the present study, out of 131 cases of 
schizophrenia in which the followup ex-
ceeded 6 months, 41 per cent of the cases 
manifested varying degrees of depression. 
Other studies revealed that the frequency 
of depression occurring in schizophrenia, 
following abatement of psychotic symp-
toms, ranged from 25 per cent of cases 
(Mc Glashan and Carpenter 1976a, Mandal 
et al 1982) to about 50 per cent of cases 
(Knights et al 1979, Johnson 1981). 
At final assessment, in cases where follo-
wup exceeded 6 months, superimposed on 
residual schizophrenia 10 percent of the 
cases developed major depressive disorder 
and 25 percent of the cases showed 'noti-
ceable' depressive symptoms (that would 
meet the cntena for minor depressive di-
sorder if 'nonpsvehotic' dimension was ig-
nored-mmor depressive disorder in RDC is 
meant for nonpsychotic episodes only). For 
depression occurring in schizophrenics fol-
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lowing abatement of psychotic symptoms, 
the term postpsychotic depression is often 
used (Mc Glashan and Carpenter 1976a). 
However, the term postpsychotic appears 
ambiguous and could be erroneouly inter-
preted as following any psychosis, that 
could be organic, reactive, epileptic, alco-
hol or drug-induced, or even manic. 'Post-
psychotic' also implies that the patient is no 
longer actively psychotic but the depres-
sion manifested by some of the cases, in this 
study, was undoubtedly of psychotic inten-
sity. It would be more appropriate to say 
that such cases were no longer actively 
schizophrenic. In the Research Diagnostic 
Criteria, the afore-mentioned depressive 
syndrome has been designated as "depres-
sive syndrome superimposed on residual 
schizophrenia (secondary depression)", 
which is too elobarate for routine labelling. 
It does not encompass cases that develop 
depressive symptoms, not sufficient to 
meet the criteria for major depression dis-
order and there is no appropriate RDC ca-
tegory for such cases as have been encoun-
tered in this study. 
The author suggests that the depressive 
syndrome superimposed on residual schi-
zophrenia could be conveniently and more 
precisely labelled as post-schizophrenic de-
pression (PSD). The term post-schizoph-
renic depression denotes that the patient is 
no longer actively schizophrenic and the 
depressive syndrome has superimposed on 
residual schizophrenia, without any activa-
tion of schizophrenic symptoms and the 
cases that develop a major depression could 
be labelled as PSD-Major and those with 
minor depression, PSD-Minor (based upon 
the severity of depression and not the ca-
usality). 
Post-schizophrenic depressive disord-
ers, in particular some of the minor depres-
sive states, might be reactive in nature ma-
nifesting as the patients recover insight into 114  DEPRESSIVE DISORDERS IN SCHIZOPHRENIA 
their illness and life situation. Such depres-
sive states might also result from guilt or 
shame patients feel in relation to their hav-
ing become psychotic (Wildroe 1966). Ho-
wever, depression occurring in a manic fol-
lowing recovery could also be construed 
as reactive in a similar fashion whereas we 
find this is not the case. In schizophrenia, 
following improvement when there is ev-
ery reason to be happy, tor major depressive 
disorder to supervene cannot be merely 
passed oil as reactive and endogenous fac-
tors seem to be operating. 
As encountered in this studv, post-schi-
zophrenic major depression was quite severe 
and stable and was often incapacitating in that 
the patients were unable to carry out any rela-
tively complex goal directed activity such as 
work, taking care of the house or participa-
tion in social and recreational activities. It, not 
infrequently, resembled a retarded major de-
pressive disorder with pervasive loss of inte-
rest or pleasure and absence of reactivity of 
mood to changes in environment was conspi-
cuous. The patients often harboured delu-
sions of sclf-repioach and guilt and suicidal 
preoccupation was prominent. 
Neuroleptic drugs have long been impli-
cated in the causation of post-schizophrenic 
depression i.e. the PSD is pharmacogenic 
(De Alarcon and Carney 1969, Ayd 1975, Fal-
loon et al 1978). In the present study, there 
was no significant difference (P< 0.05) bet-
ween the number of schizophrenics de-
pressed before neuroleptic treatment (49) 
and those that manifested depression at fol-
low-up (56). It would thus appear that neuro-
leptics play no role in the causation of depres-
sive symptoms. However, further analysis 
showed that neuroleptics might have pro-
minent depressogenic effects. In 23 out of 49 
depressed schizophrenics, depressive symp-
toms had abated at the end of 8 weeks of 
neuroleptic treatment, and the initial de-
pression persisted in only 26 cases at final 
followup. Out of 56 cases manifesting de-
pression at followup, 30 cases (53%) had no 
depressive symptoms at first presentation 
and they revealed depression following 
neuroleptic treatment. These findings in-
dicate that depression might develop de 
novo following neuroleptic treatment of 
schizophrenia in some cases and depression 
in such cases does not represent an already 
existing symptom complex. None ot the 
schizophrenics, in this study, had major de-
pressive disorder at the beginning of 
treatment (since a prominent affective 
syndrome was an exclusion criterion tor 
diagnosis of schizophrenia), whereas fol-
lowing neuroleptic treatment, superim-
posed on residual schizophrenia, 16 cases 
manifested major depressive disorder. It is 
probable that neuroleptics also cause aggra-
vation of existing depressive symptomato-
logy. However, this is unlikely to be a 
simple relationship, since in some double-
blind trials, the placebo group has expe-
rienced an identical frequency of depres-
sion as the active drug recipients (Lett and 
Wing 1971, Hirsch et al 1973). Some stu-
dies have refuted the concept of 'pharma-
cogenic' depression in schizophrenia 
(Strain et al 1982, Roy et al 1984). The oc-
currence of depressive symptoms in the 
course of schizophrenia was also sporadi-
cally noted even before the intri>diiction ot 
neuroleptics (Mayer-Gross 1920. Lewis 
and Hubbard 1931, Eissler 1951, Lewis and 
Piotrowski 1954). These findings suggest 
that depression could be an inherent part ot 
schizophrenia, though neuroleptics may 
have a role in precipitating depressive di-
viders in schizophrenia. 
Some authors (Rifkin et al 1975, Van 
Putten and May 1978) have advanced the 
concept of 'akinetic depression' in schi-
zophrenia, to refer to a syndrome resembl-
ing depressive illness, which occurs in asso-
ciation with drug-induced Parkinsonism. 
Van Putten and May (1978) reported that 
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leviating such depression, while Quitkin et 
al (1978) pointed out that those symptoms 
which respond to anticholinergics were 
part of drug-induced Parkinsonism. Moller 
and Zerssen (1981) found that depressive 
symptoms were as common in schizoph-
renics on anticholinergics as in those who 
were not. In the present study, antiparkin-
sonian drugs were routinely used along 
with neuroleptics and drug induced akine-
sia appeared less likely as a source of ob-
served depressive states. Hirsch (1982) 
concluded that there was little reason to re-
gard the akinetic syndrome as a form of de-
pression, though the concept had heuristic 
value to remind us that apparently anergic 
depressed schizophrenics might have drug-
induced Parkinsonism. 
It has to be noted that certain "negative 
symptoms" described in schizophrenia seem 
to have semblance to some of the depressive 
symptoms described here. The negative 
symptoms of schizophrenia include impove-
rished speech, affective flattening, avolition 
apathy, loss of libido, anhedonia, social 
withdrawal and attentional impairment 
(Andreasen 1982, Andreasen-Olscn 1982, 
Lewine ct al 1983). However, many of the 
individual negative symptoms such as po-
verty of speech", physical anergia, anhedo-
nia-asociality complex, also occur, in de-
pressive illness (Andreasen 1982). A sharp 
demarcation between negative schizoph-
renic symptoms and postschizophrenic de-
pressive symptoms docs not exist and at- » 
tempts directed at this are bound to be con-
troversial. As assessed in this study, the de-
pressive manifestations included a painful 
depressive affect rather than a blunted af-
fect and a constellation of other affective 
symptoms including pervasjve loss of inte-
rest or pleasure, feelings of self-reproach or 
guilt, recurrent thoughts of death or suicide 
or any suicidal behaviour, which reflect 
more a depressed state than a negative schi-
zophrenia. Moreover, some ot the residual 
symptoms such as emotional blunting and ex-
treme social withdrawal were prerequisites 
for a diagnosis of residual schizophrenia in 
this study, and the depressive states noted in 
such cases were in addition to the negative 
symptoms of schizophrenia. Negative schi-
zophrenia is similar to the concept of 
simple schizophrenia (Andreasen and Ol-
sen 1982), negative symptoms in schizoph-
renia do not appear to be related to a pos-
sible postpsychotic depression, the latter 
being relatively time-limited (Pogue-Geile 
and Harrow 1984). 
4 cases (3%) in whom schizophrenic 
symptoms were still active, developed su-
perimposed major depressive disorder in 
the course of time and it appears that some 
cases presenting as schizophrenia later pro-
gress to schizo-affectivc disorder. 3 cases 
(2%) in whom schizophrenic symptoms re-
mitted totally, thereafter developed major 
depressive disorder. In the absence of resi-
dual schizophrenic symptoms, these cases 
cannot be equated with postschizophrenic 
depression and the RDC label of secondary 
major depressive disorder seems appropri-
ate for such cases. In these cases the initial 
diagnosis of schizophrenia was not in doubt 
and only one of them manifested 'noticeab-
le' depressive symptoms at first presenta-
tion. It is not clear how such a transforma-
tion could take place; nevertheless, some 
studies in the past revealed that some cases 
of schizophrenia later develop manic-de-
pressive illness (Ziskind et al 1971, Shcld-
rick ct al 1977, Sartonus et al 1977, Mellor 
ct al 1981). 
Thus, it is clear that depressive symp-
toms occur in schizophrenia at the onset of 
illness and over a course of time with or wi-
thout treatment; hence, depression must be 
intrinsic of schizophrenia. It could be that 
schizophrenia shares a common pathophy-
siological mechanism with depression and 
neuroleptic-induced improvement in schi-
zophrenia might thus unmask or precipit-116  DEPRESSIVE DISORDERS IN SCHIZOPHRENIA 
ate depression. Hirsch (1982, 1983) refutes 
the concept of neuroleptic-induced depres-
sion and proposes that depressive symp-
toms are an integral part or schizophrenic 
symptoms and must, therefore, share with 
schizophrenia common pathophysiological 
processes. Galdi (1983), while disagreeing 
with the views expressed by Hirsch (1982), 
advances the concept of 'pharmacogenetic 
depression' which occurs in genetically pre-
disposed schizophrenic patients following 
neuroleptic treatment. Though, the views 
of Galdi and Hirsch look apparently dissi-
milar, it is evident that both of them em-
phasize intrinsic mechanisms. 
The patients included in this report can 
be regarded as definitive cases of schizoph-
renia in view of the exclusion criteria. 
However, the retrospective application of 
RI)C criteria and lack of uniformity in the 
duration of followup pose certain limita-
tions. Prospective studies using operational-
ly defined criteria for the diagnosis of schi-
zophrenia and objective methods of evalua-
tion for assessment of depressive synd-
romes in such cases are in order and the cau-
sality of depressive mood disorders in schi-
zophrenia, which may well be hetero-
genous, needs to be re-examined. 
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